WASHINGTON, Feb 19 (Reuters) - Avastin, one of a new family of drugs that starves tumors of their blood supply, can slow the growth of the most common and deadly form of brain cancer, researchers reported on Monday.
Avastin combined with standard chemotherapy could temporarily stop the growth of brain tumors known as gliomas, the researchers reported in the journal Clinical Cancer Research.
Made by Genentech (DNA.N: Quote, Profile , Research) under the chemical name bevacizumab, Avastin is currently approved to treat lung and colorectal cancers.
"These results are exciting because of the possible implications for a patient population that currently has the poorest possible prognosis going into treatment -- those with malignant brain tumors that have recurred after initial treatment," said Dr. James Vredenburgh of Duke University, who led the study.
I take it very positively. Validates where we are heading. Look at all the satins (Lipitor, Vitoren, Crestor etc... etc...) in the market and how they all make money and big money at that. We have a solution to not just one problem/disease but several. Everyone's body is a little different, so different drugs and or combinations of drugs will be more successful/effective in one case versus another.